View : 15 Download: 0

Effect of Tamsulosin in Lower Urinary Tract Symptom Patients With Metabolic Syndrome

Title
Effect of Tamsulosin in Lower Urinary Tract Symptom Patients With Metabolic Syndrome
Authors
Yoon H.Yoon H.S.Lee Y.S.Cho S.T.Han D.H.
Ewha Authors
윤하나윤현석
SCOPUS Author ID
윤하나scopus; 윤현석scopus
Issue Date
2016
Journal Title
Urology
ISSN
0090-4295JCR Link
Publisher
Elsevier Inc.
Indexed
SCI; SCIE; SCOPUS WOS scopus
Abstract
Objective: To investigate the efficacy of tamsulosin, a selective alpha-1 blocker, in lower urinary tract symptoms (LUTS) patients with metabolic syndrome (MS). Patients and Methods: This prospective, multicenter clinical trial included men and women (20-75 years old) with LUTS, with or without MS. Patients were categorized as MS+ or MS-, respectively, and all of them were administered tamsulosin 0.2 mg per oral once daily for 24 weeks. Patients were assessed based on the International Prostate Symptom Score, King's Health Questionnaire (KHQ), Overactive Bladder Questionnaire, uroflowmetry with postvoid residuals, and MS factors (blood pressure, waist-to-hip ratio, and serum levels of fasting blood glucose, triglyceride, and high-density lipoprotein cholesterol) at baseline and at 4, 12, and 24 weeks of treatment. Results: Ninety-two patients were enrolled in this study (53/92 were MS- [57.6%]; 39/92 were MS+ [42.4%]). After 24 weeks of tamsulosin treatment, fasting blood glucose (P = .02) and triglyceride (P < .001) levels of changes were significantly greater in the MS+ group than in the MS- group. Total International Prostate Symptom Score, total Overactive Bladder Questionnaire score, and the scores of each question on the KHQ showed significant improvement after treatment without intergroup differences. In KHQ, although improvements in emotional status, sleep quality, fatigue, and personal distress were greater in the MS+ group (P = .05), the difference between the groups did not reach statistical significance. Conclusion: Tamsulosin was effective in both LUTS patients with and without MS. Furthermore, tamsulosin had beneficial effects on some of the factors associated with MS. © 2015 Elsevier Inc.
DOI
10.1016/j.urology.2015.07.074
Appears in Collections:
의학전문대학원 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE